The Biden administration plans to share at least some results of IRA drug price negotiations on Thursday, according to a Politico report that cited anonymous sources.
Negotiations were scheduled to end on Aug. 1, and many drugmakers whose products were picked for the negotiations have said in recent weeks that they expect to absorb the impact of the law when the new prices go into effect in 2026. The negotiations have been ongoing for months.
Some portion of the results of those back-and-forth talks will be released before the stock market opens on Thursday, Politico reported. It’s not clear if what’s disclosed will include actual prices for individual drugs, or more general descriptions, such as how much patients might save in aggregate.
If the Biden administration does disclose the drug-by-drug negotiated prices, it would be doing so several weeks ahead of its Sept. 1 deadline. Later Thursday, President Biden and Vice President Kamala Harris are scheduled to appear at an event in Maryland to “deliver remarks on the progress they are making to lower costs for the American people.”
Representatives for the White House and the Department of Health and Human Services didn’t immediately return requests for comment.